Monday, June 15, 2026

AWS lights up Korean dev scene with GenAI Amazon Q

AWS enhances its generative AI service, Amazon Q Developer, to support Korean, aiding local developers in various tasks.

North Korean Workers’ Riot in China Signals Potential Start of Labor Movement

Last month, a significant riot by North Korean workers in China over unpaid wages hinted at the emergence of a potential labor movement within North Korea.

SEC Prepares New Framework to Allow Blockchain-Based Trading of Tokenized Stocks

The SEC plans to unveil rules allowing blockchain-based stock token trading, enhancing flexibility in securities markets.

Tag: drug

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Over Half of Top Propofol-Using Clinics in Asia Found Violating Drug Control Law

Authorities found widespread narcotics violations in medical institutions using propofol, with over half inspected breaching regulations.

Pangen Expands Cell-Based Bioassay Services for Customized Drug Development

Pangen is expanding its cell-based activity analysis services after a new contract, enhancing drug evaluation capabilities for various medications.

Unlocking Cancer Treatment: How TXN12923 Targets ULK1 for Enhanced Drug Sensitivity

Txinno Bioscience to present TXN12923, a novel ULK1 targeted protein degrader, at AACR, aiming to enhance cancer treatment efficacy.

Daewoong’s Hub System Aims to End Drug Shortages With Predictive Data

Daewoong Pharmaceutical is enhancing drug distribution with a data-driven hub system for better inventory management and transparency.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

Hemlibra Breakthrough: 91% of Hemophilia Patients in Japan Experience No Adverse Reactions!

JW Pharmaceutical's Hemlibra shows 91% safety in Japanese hemophilia patients, with no adverse reactions in long-term study.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

Column-Free Antibody Purification Breakthrough: 97%+ Purity, 4x Faster, and 12x Fewer Impurities

KICET introduces a cost-effective antibody purification system using Tangential Flow Filtration, enhancing efficiency and purity in drug production.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.